跳至主要内容
临床试验/JPRN-UMIN000008325
JPRN-UMIN000008325已完成未知

Effect of T/L-type calcium channel blockers on serum biomarkers for cardiovascular function - BAM-Kobe Study

Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2012年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with severe uncontrolled hypertension (diastolic BP over 110 mmHg), secondary hypertension, hyperuricemia, a past history of gout attack, poorly controlled [glycated hemoglobin A1c (HbA1C over 8.0] or insulin-treated diabetes mellitus, cardiovascular events including myocardial infarction and stroke within the preceding 3 months, severe liver dysfunction, renal failure (serum creatinine over 2.0 mg/dL), active malignancy, pregnancy, severe bile dysfunction, or allergy to benidipine or amlogipin were excluded from the study.

研究者

发起方
Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine

相似试验